Pharmaceutical Executive September 24, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

The Financial Benefits of Technology

In the final part of his interview with Pharma Commerce Editor Nicholas Saraceno, Kevin MacDonald, Bluesight’s Co-founder and CEO, explains the amount of time it takes to see a reduction in annualized drug spend, and offers estimates in terms of percent savings.

What Diabetes Taught Me That Pharmacy School Did Not

Empathy is being left outside the exam room door.

Will A.I. Be a Bust? A Wall Street Skeptic Rings the Alarm.

Jim Covello, Goldman Sachs’s head of stock research, warned that building too much of what the world doesn’t need “typically ends badly.”

Kenvue Drives Climate Action Strategy Forward

Kenvue Inc., the maker of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article